Therapeutic experiences in melanoma patients
Szodoray, L.; Vezekenyi, C.
Dermatologische Monatschrift 156(5): 445-447
1970
ISSN/ISBN: 0011-9083 PMID: 5509146 Document Number: 29096
Document emailed within 1 workday
Related Documents
Konjević, G.; Jović, V.; Radulović, S.; Jelić, S.; Dzodić, R.; Spuzić, I. 2001: Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha Neoplasma 48(3): 175-181Terada, T.; Ishikawa, S.; Katayama, T. 1985: Therapeutic experiences of seishinrenshiin in patients with equivocal complaints of the lower urinary tract Hinyokika Kiyo. Acta Urologica Japonica 31(7): 1253-1256
Berg, A.; Delventhal, G. 1973: New therapeutic possibilities for local treatment of acneiform dermatosis. Experiences with large numbers of patients Die Medizinische Welt 24(3): 84-87
Witte, M.E.; Gerrits, E.G.; Klaase, J.M.; Mastboom, W.J.B.; Sterk, L.M.T. 2006: Distinguishing nodal naevus from melanoma metastases in the sentinel node in patients with melanoma Nederlands Tijdschrift Voor Geneeskunde 150(19): 1072-1076
Akimaru, K.; Shoji, T.; Seigler, H.F. 1984: In vivo evaluation of cellular immunity in melanoma patients against melanoma Nihon Geka Gakkai Zasshi 85(2): 93-101
Bernengo, M.G.; Doveil, G.C.; Lisa, F.; Pippione, M.; Aloi, F.G.; Stuardi, C.; Zina, G. 1986: Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985) Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 121(5): 311-326
Buraggi, G.L.; Callegaro, L.; Mariani, G.; Turrin, A.; Cascinelli, N.; Attili, A.; Bombardieri, E.; Terno, G.; Plassio, G.; Dovis, M. 1985: Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments Cancer Research 45(7): 3378-3387
Bernengo, M.G.; Doveil, G.C.; Lisa, F.; Stuardi, C.; Zina, G. 1987: Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985) Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 122(4): 143-153
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Cuesta Alcalá, J.A.; Caballero Martínez, M.C.; Ripa Saldías, L.; Pascual Piédrola, I.; Solchaga Martínez, A.; Aldave Villanueva, J.; Arrondo Arrondo, J.L.; Grasa Lanau, V.; Ponz González, M.; Ipiens Aznar, A. 2001: Therapeutic approach in adrenal melanoma. Review of the literature Archivos Espanoles de Urologia 54(7): 685-690
Melita, P.; Barbuscia, M.; Calbo, L.; Belnome, N.A.; Palmeri, R.; Lazzara, S.; Lorenzini, C. 1989: Malignant melanoma of the skin: current diagnostic and therapeutic approaches Chirurgia Italiana 41(4-6): 167-179
Ingvar, C.; Erichsen, C.; Jönsson, P.E. 1984: Morbidity following prophylactic and therapeutic lymph node dissection for melanoma--a comparison Tumori 70(6): 529-533
Nepomniashchaia, E.M.; Gusareva, M.A.; Petrov, S.V. 2008: Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities Voprosy Onkologii 54(6): 744-748
Ladewig, D.; Graw, P. 1982: Therapeutic experiences and prognosis in heroin dependence Therapeutische Umschau. Revue Therapeutique 39(8): 586-593
Guercini, G.; Celani, M.G. 1989: Use of the "N of 1" method for determining therapeutic choice: first experiences Medicina 9(2): 206-208
Zapp, E. 1970: Diagnostic and therapeutic experiences in childhood enuresis Medizinische Monatsschrift 24(9): 386-394
Acs, M.; Toth, B. 1962: Our experiences with the administration of formalin in therapeutic abortions in the aged Magyar Noorvosok Lapja 25: 33-37
Wang, Y.; Cen, Y.; Li, Z. 2007: Therapeutic result of operation combined with large-dose of roferon-A for cutaneous malignant melanoma Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21(1): 37-39
Jungi, W.F.; Senn, H.J.; Beckmann, C.; Flury, R.; Frei, P.; Holdener, E. 1975: Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors Schweizerische Medizinische Wochenschrift 105(42): 1365-1369
Garbe, C.; Zouboulis, C.C.; Krüger, S.; Waibel, M.; Kreuser, E.D.; Stadler, R.; Orfanos, C.E. 1992: Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 43(1): 4-10